Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1683351

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1683351

Spain Food Supplement Market -2025-2028

PUBLISHED:
PAGES: 290 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3175
PDF & Excel (Multiple User License)
USD 3500
PDF & Excel (Enterprise License)
USD 6850

Add to Cart

The Spain food supplement market was worth US$ 1,811.22 million in 2024 and is expected to reach US$ 2475.21 million in 2028, growing at a CAGR of 8.48% during the forecast period (2025-2028).

The Spain food supplements market is experiencing steady growth, driven by increasing consumer awareness of preventive healthcare, wellness trends, and personalized nutrition. For instance, according to data reflected in the new edition of the FOOD Barometer, 3 in 4 Spaniards are more aware of their health and of following a healthy diet since the COVID-19 pandemic. Furthermore, according to Bord Bia, the Irish Food Board, 55.4% of consumers are willing to spend more on healthier food options.

Additionally, the aging population in Spain is a key driver, as elderly individuals seek gut health, immunity-boosting, and cognitive support supplements to maintain long-term well-being. Additionally, the growth of e-commerce and digital health platforms has made supplements more accessible, with major online pharmacies and direct-to-consumer brands expanding their reach.

Government-backed health awareness initiatives and nutrition programs further support market growth by educating consumers about the benefits of dietary supplements. The market also benefits from strong R&D investments, with companies introducing scientifically backed, innovative formulations that cater to specific health concerns.

Drivers

Growing Aging Population

Spain's rapidly aging population is a key driver of the country's food supplement market. By 2050, Spain's aging population is projected to exceed 36%, according to the NIH, highlighting a growing demographic shift towards an older society. This increase will likely intensify economic and social challenges related to elderly care and workforce sustainability. As life expectancy increases, older adults are prioritizing preventive healthcare, fueling demand for supplements that support joint health, bone density, cardiovascular function, and cognitive well-being.

Omega-3 fatty acids, calcium, vitamin D, and collagen supplements are particularly popular among seniors seeking to maintain mobility and independence. Additionally, rising concerns about age-related diseases such as osteoporosis, arthritis, and dementia are pushing demand for specialized formulations. Immunity-boosting supplements, including probiotics and vitamin C, are also gaining traction as older individuals focus on strengthening their immune systems. The increasing prevalence of digestive issues among seniors is further driving demand for gut health products like probiotics and fiber supplements.

Increasing Demand for Personalized Supplements

The demand for personalized supplements is transforming Spain's food supplement market, driven by consumers seeking tailored health solutions based on their genetics, lifestyle, and dietary needs. Advances in DNA testing, microbiome research, and AI-driven nutrition are enabling brands to offer customized formulations that cater to specific goals like immune support, cognitive function, weight management, and gut health. Subscription-based and direct-to-consumer (DTC) models are thriving, providing convenient, science-backed supplement packs.

For instance, in 2024, Oriflame introduced a personalized nutrition service in Spain under its Wellosophy brand, offering custom supplement packs based on individual health needs. Through an online assessment, consumers provide details on their diet, lifestyle, and wellness goals, which are analyzed to recommend tailored supplements targeting areas like immunity, sleep, skin health, and energy. This initiative aims to make supplementation easy and sustainable while supporting each customer's unique health journey.

Restraints

Stringent Regulatory Environment

The stringent regulatory framework and compliance challenges in Spain significantly restrain the growth of the food supplements market by imposing strict approval processes, labeling requirements, and ingredient restrictions under the European Food Safety Authority (EFSA) and national laws. Companies must ensure compliance with Royal Decree 1487/2009, which aligns with EU regulations, making product launches and reformulations time-consuming and costly.

For instance, EFSA's restrictions on health claims prevent manufacturers from marketing supplements with unapproved claims, limiting their ability to highlight benefits effectively. Additionally, frequent updates to legislation create uncertainty for businesses, requiring continuous adjustments to formulations and packaging, which adds to operational costs. The ban on certain ingredients and high-dose vitamins also forces companies to reformulate products, delaying market entry.

A notable example is the restriction on certain botanical extracts, which led to the reformulation of herbal supplements, impacting sales and consumer trust. Furthermore, compliance costs make it difficult for small and medium-sized enterprises (SMEs) to compete with larger brands that have the resources to navigate complex regulatory requirements. These challenges collectively slow down innovation, increase costs, and limit product availability, thereby restraining overall market growth.

Segment Analysis

The Spain food supplement market is segmented based on ingredients, dosage, application, age, and distribution channel.

Growing Demand for Probiotics, Prebiotics, and Digestive Support Products

Gastrointestinal health holds a significant share in the food supplement market in Spain due to increasing consumer awareness of gut health's impact on overall well-being. The demand for probiotics, prebiotics, and digestive enzymes has surged, driven by rising digestive disorders, lifestyle changes, and a growing aging population. In February 2023, ADM launched a new $30 million production facility in Valencia, Spain, increasing its probiotics and postbiotics capacity to 50 metric tons per year. The facility, the first to produce both at the same site, supports ADM's expansion into global health and wellness markets.

Additionally, regulatory support from the European Food Safety Authority (EFSA) ensures product efficacy and transparency, increasing consumer trust. With a preference for natural and plant-based formulations, Spanish consumers are embracing clean-label and organic gut health supplements. The market is also influenced by the Mediterranean diet, which promotes digestive well-being, reinforcing the demand for complementary supplements.

Sustainability Analysis

Spain has a growing demand for natural and organic supplements, driving companies to adopt sustainable sourcing of ingredients, including plant-based and marine-derived options. Eco-friendly packaging, such as biodegradable or recyclable materials, is becoming a priority to reduce plastic waste. Regulatory frameworks, including EU sustainability policies, push manufacturers toward responsible production and ethical labor practices. The industry is also shifting towards carbon-neutral operations, with brands investing in renewable energy and reducing emissions.

Ethical sourcing and fair-trade certifications are gaining traction to ensure biodiversity conservation and fair labor conditions. Spain's consumer awareness about sustainability is increasing, leading brands to prioritize transparency and traceability in the supply chain. Companies are adopting circular economy principles, repurposing waste materials into new products. Digitalization is enhancing efficiency, reducing waste, and improving logistics to lower the carbon footprint. Sustainable farming practices, such as regenerative agriculture, are gaining importance for ingredient cultivation. Collaborations between businesses, government, and NGOs are fostering industry-wide sustainability improvements.

Unmet Needs

While personalized nutrition is gaining traction, there is still a gap in tailor-made supplement solutions catering to specific demographics, such as pregnant women, menopausal women, and individuals with chronic conditions like diabetes or cardiovascular diseases. Most products offer generalized formulations, limiting the effectiveness of individual health needs.

Traditional supplement formats like pills and capsules dominate the market, but there is a growing demand for more convenient and enjoyable consumption methods, such as gummies, dissolvable powders, and functional beverages. Many consumers, especially elderly individuals and children, find swallowing pills inconvenient, leading to low adherence to supplement regimens.

While urban consumers have easy access to a wide variety of supplements, many rural areas in Spain still face limited product availability and awareness about dietary supplements. A lack of educational initiatives and targeted marketing campaigns in these regions results in lower adoption rates.

Although sustainability is becoming a key focus, the Spanish market still lacks sufficient eco-friendly supplement packaging, carbon-neutral production, and ethically sourced ingredients. Consumers are increasingly looking for plastic-free, biodegradable, and refillable supplement packaging, yet such options remain limited in availability.

Despite rising demand, many supplements lack strong clinical evidence or transparent labeling, leading to consumer skepticism. There is an increasing need for more research-backed formulations, third-party testing, and clear health claims to build trust and credibility.

Competitive Landscape

The major players in the market include AB-BIOTICS, SA, Laboratorios Ordesa, S.L., Faes Farma S.A, TOP4U, BIOITHAS SL, DRKU (Korott), Nestle Espana SA (Nestle S.A.), BioGaia, DANONE Spain (Danone SA), Procter & Gamble Spain (Procter & Gamble), Chiesi Spain SAU (Chiesi Farmaceutici S.p.A), STADA Spain (STADA Arzneimittel AG) and others.

By Ingredient

  • Vitamins
  • Botanicals
  • Minerals
  • Protein & Amino Acids
  • Omega Fatty Acids
  • Probiotics
  • Others

By Dosage

  • Tablet
  • Capsules
  • Liquid
  • Powder
  • Others
    • Chewables & Gummies
    • Soft Gels
    • Others

By Application

  • Gastrointestinal Health
    • Gut Microbiota/Microbiome Balance
    • Digestion
    • Constipation
    • Bloating
    • Diarrhea
    • Leaky Gut
    • Inflammation
    • Immune System
    • Others
  • Gluten sensitivity
  • Abdominal Pain
  • GERD/Helicobacter pylori
  • Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
  • Gut Flora/Gut Microbiome Restoration
  • Others
  • Vaginal Health
  • Urinary Tract Health
    • Kidney Stones
    • UTIs
    • Others
  • Oral Health
  • Anti/Healthy Ageing
  • Allergies/Asthma
  • Bone & Joint Health
    • Osteoarthritis
    • Osteoporosis/Low Mineral Bone Density
    • Inflammation
  • Brain/Mental Health
    • Sleep
    • Cognition
    • Mood
    • Depression
    • Focus
  • Cardiovascular Health
  • Circulation
  • Energy/Fatigue Reduction
  • Metabolic Syndrome/Blood Glucose
  • Liver Health
  • Energy
  • Immunity/Respiratory Infections
  • Nutrient Absorption
  • Skin-Hair-Nails
    • Atopic Dermatitis & Eczema
    • Acne
    • Rosacea
    • Hair Growth/Hair Loss
    • Skin Microbiome
    • Others
  • Sports
  • Women's Health
    • Fertility
    • Menopause
    • Pregnancy
    • Pcos
    • Vaginal Health & Health Vaginal Microbiome
    • Vaginal Infections (Bv/Vvc)
    • Pregnancy Outcomes
    • Others
  • Men's Health & Men's Fertility
  • Weight Management
  • Pediatric Health
    • Colic
    • Constipation
    • Regurgitation
    • Atopic Dermatitis
    • Others
  • Others

By Age

  • Infant
  • Children
  • Adults
  • Seniors

By Distribution Channels

  • Online Retailers
  • Pharmacies and Drug Stores
  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Other Distribution Channels

Key Developments

  • In December 2023, Nestle strengthened its presence in Spain by introducing its Nestle Health Science division at the Sebares plant in Asturias. The company invested over €7 million to establish a new production line for adult food supplements, with an annual capacity of 10,000 tonnes. This move enhances Nestle's nutritional health product offerings in the region.
  • In July 2023, Danone launched Almimama, a new science-based probiotic supplement in Spain to support breastfeeding. Backed by clinical research, Almimama contains Ligilactobacillus salivarius PS2, a patented probiotic strain that may help reduce the incidence of mastitis. This innovation reinforces Danone's commitment to maternal health and well-being.

Why Purchase the Report?

  • To visualize the Spain food supplement market segmentation based on ingredient, dosage, application, age, and distribution channel, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Spain Food Supplement market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Spain Food Supplement report would provide approximately 51 tables, 65 figures and 290 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB9265

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Ingredient
  • 3.2. Snippet by Dosage
  • 3.3. Snippet by Application
  • 3.4. Snippet by Age
  • 3.5. Snippet by Distribution Channel

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Aging Population
      • 4.1.1.2. Increasing Demand for Personalized Supplements
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Environment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Ingredient

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 6.1.2. Market Attractiveness Index, By Ingredient
  • 6.2. Vitamins*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Botanicals
  • 6.4. Minerals
  • 6.5. Protein & Amino Acids
  • 6.6. Omega Fatty Acids
  • 6.7. Probiotics
  • 6.8. Others

7. By Dosage

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 7.1.2. Market Attractiveness Index, By Dosage
  • 7.2. Tablet*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Capsules
  • 7.4. Liquid
  • 7.5. Powder
  • 7.6. Others
    • 7.6.1. Chewables & Gummies
    • 7.6.2. Soft Gels
    • 7.6.3. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Gastrointestinal Health*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Gut Microbiota/Microbiome Balance
    • 8.2.4. Digestion
    • 8.2.5. Constipation
    • 8.2.6. Bloating
    • 8.2.7. Diarrhea
    • 8.2.8. Leaky Gut
    • 8.2.9. Inflammation
    • 8.2.10. Immune System
    • 8.2.11. Others
      • 8.2.11.1. Gluten sensitivity
      • 8.2.11.2. Abdominal Pain
      • 8.2.11.3. GERD/Helicobacter pylori
      • 8.2.11.4. Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
      • 8.2.11.5. Gut Flora/Gut Microbiome Restoration
      • 8.2.11.6. Others
  • 8.3. Vaginal Health
  • 8.4. Urinary Tract Health
    • 8.4.1. Kidney Stones
    • 8.4.2. UTIs
    • 8.4.3. Others
  • 8.5. Oral Health
  • 8.6. Anti/Healthy Ageing
  • 8.7. Allergies/Asthma
  • 8.8. Bone & Joint Health
    • 8.8.1. Osteoarthritis
    • 8.8.2. Osteoporosis/Low Mineral Bone Density
    • 8.8.3. Inflammation
  • 8.9. Brain/Mental Health
    • 8.9.1. Sleep
    • 8.9.2. Cognition
    • 8.9.3. Mood
    • 8.9.4. Depression
    • 8.9.5. Focus
  • 8.10. Cardiovascular Health
  • 8.11. Circulation
  • 8.12. Energy/Fatigue Reduction
  • 8.13. Metabolic Syndrome/Blood Glucose
  • 8.14. Liver Health
  • 8.15. Energy
  • 8.16. Immunity/Respiratory Infections
  • 8.17. Nutrient Absorption
  • 8.18. Skin-Hair-Nails
    • 8.18.1. Atopic Dermatitis & Eczema
    • 8.18.2. Acne
    • 8.18.3. Rosacea
    • 8.18.4. Hair Growth/Hair Loss
    • 8.18.5. Skin Microbiome
    • 8.18.6. Others
  • 8.19. Sports
  • 8.20. Women's Health
    • 8.20.1. Fertility
    • 8.20.2. Menopause
    • 8.20.3. Pregnancy
    • 8.20.4. Pcos
    • 8.20.5. Vaginal Health & Health Vaginal Microbiome
    • 8.20.6. Vaginal Infections (Bv/Vvc)
    • 8.20.7. Pregnancy Outcomes
    • 8.20.8. Others
  • 8.21. Men's Health & Men's Fertility
  • 8.22. Weight Management
  • 8.23. Pediatric Health
    • 8.23.1. Colic
    • 8.23.2. Constipation
    • 8.23.3. Regurgitation
    • 8.23.4. Atopic Dermatitis
    • 8.23.5. Others
  • 8.24. Others

9. By Age

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 9.1.2. Market Attractiveness Index, By Age
  • 9.2. Infant*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Children
  • 9.4. Adults
  • 9.5. Seniors

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Online Retailers*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pharmacies and Drug Stores
  • 10.4. Supermarkets/Hypermarkets
  • 10.5. Convenience Stores
  • 10.6. Other Distribution Channels

11. Sustainability Analysis

  • 11.1. Environmental Analysis
  • 11.2. Economic Analysis
  • 11.3. Governance Analysis

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. AB-BIOTICS, SA*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Laboratorios Ordesa, S.L.
  • 13.3. Faes Farma S.A
  • 13.4. TOP4U
  • 13.5. BIOITHAS SL
  • 13.6. DRKU (Korott)
  • 13.7. Nestle Espana SA (Nestle S.A.)
  • 13.8. BioGaia
  • 13.9. DANONE Spain (Danone SA)
  • 13.10. Procter & Gamble Spain (Procter & Gamble)
  • 13.11. Chiesi Spain SAU (Chiesi Farmaceutici S.p.A)
  • 13.12. STADA Spain (STADA Arzneimittel AG)

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!